Filtered By:
Management: Medicaid

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 545 results found since Jan 2013.

Universal Coverage Means Less Care and More Money
By JANE ORIENT, MD The reported success of the Affordable Care Act (ACA or ObamaCare) is based on enrollment numbers. Millions more have “coverage.” Similarly, the predicted disasters from repeal have to do with loss of coverage. Tens of thousands of deaths will allegedly follow. Activists urge shipping repeal victims’ ashes to Congress—possibly illegal and certainly disrespectful of the loved one’s remains, which will end up in a trash dump. Where are the statistics about the number of heart operations done on babies born with birth defects, the latest poster children? How about the number of babies saved by th...
Source: The Health Care Blog - May 17, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized enrollment numbers Jane Orient Universal coverage Source Type: blogs

Medicaid: What Happens Now?
With public attention completely focused on the wild effort to reach closure on the private health insurance provisions of the American Health Care Act (AHCA) (H.R. 1628), it was easy to overlook (at least for a moment) the extraordinary nature of its Medicaid changes. Were these provisions to become law, the AHCA would represent the most sweeping federal policy shift since the program’s 1965 enactment. How The AHCA Would Affect Medicaid The AHCA would end the Affordable Care Act’s enhanced funding for the adult expansion population. More profoundly, however—and completely disconnected from the AHCA’s “repeal...
Source: Health Affairs Blog - May 17, 2017 Category: Health Management Authors: Sara Rosenbaum Tags: Costs and Spending Featured Following the ACA Insurance and Coverage Medicaid and CHIP Quality ACA repeal and replace AHCA EPSDT Medicaid block grants Medicaid expansion Medicaid per capita cap medicaid work requirement Source Type: blogs

Stripping Title X funding means women are robbed of health care
Barely ten years ago, 350,000 completely preventable AIDS deaths occurred in South Africa because of their president’s obstinacy. He recommended that women treat their HIV with beetroot and lemon juice. It’s hard to believe until you realize the same thing just happened here. HJ Resolution 43 was just signed into law by President Trump, giving states the ability to reject federal grants (called Title X grants) to family planning providers and clinics that help low-income patients receive physical exams, labs, prescriptions, contraception, mammograms, cervical cancer screenings, and — yes — referrals for STIs and HI...
Source: Kevin, M.D. - Medical Weblog - May 12, 2017 Category: General Medicine Authors: < a href="http://www.kevinmd.com/blog/post-author/sarah-lawrence" rel="tag" > Sarah Lawrence < /a > Tags: Policy OB/GYN Source Type: blogs

The Louisiana Purchase
By ROBERT PEARL, MD “Pigs get fat, but hogs get slaughtered,” the saying goes. And so may it prove to be true for the pharmaceutical industry. Three articles, all published recently, illustrate the greed and egregious pricing by certain drug companies that are gaining public recognition and scrutiny. Marathon Pharmaceuticals LLC serves as a case in point. Over the last 15 years, its chairman and CEO Jeffrey Aronin generated a billion-dollar valuation for the company. As reported in a Wall Street Journal article, “Drug Price Revolt Prods a Pioneer to Cash Out,” he achieved this milestone not by inventing ne...
Source: The Health Care Blog - May 12, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Source Type: blogs

New Checks and Balances For Big Pharma
By ROBERT PEARL, MD “Pigs get fat, but hogs get slaughtered,” the saying goes. And so may it prove to be true for the pharmaceutical industry. Three articles, all published recently, illustrate the greed and egregious pricing by certain drug companies that are gaining public recognition and scrutiny. Marathon Pharmaceuticals LLC serves as a case in point. Over the last 15 years, its chairman and CEO Jeffrey Aronin generated a billion-dollar valuation for the company. As reported in a Wall Street Journal article, “Drug Price Revolt Prods a Pioneer to Cash Out,” he achieved this milestone not by inventing ne...
Source: The Health Care Blog - May 12, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Source Type: blogs

The Little Louisiana Purchase
By ROBERT PEARL, MD “Pigs get fat, but hogs get slaughtered,” the saying goes. And so may it prove to be true for the pharmaceutical industry. Three articles, all published recently, illustrate the greed and egregious pricing by certain drug companies that are gaining public recognition and scrutiny. Marathon Pharmaceuticals LLC serves as a case in point. Over the last 15 years, its chairman and CEO Jeffrey Aronin generated a billion-dollar valuation for the company. As reported in a Wall Street Journal article, “Drug Price Revolt Prods a Pioneer to Cash Out,” he achieved this milestone not by inventing ne...
Source: The Health Care Blog - May 12, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Source Type: blogs

It ’ s Time to Truly Share the Chemo Decision With Cancer Patients
By MICHAEL MILLENSON You (or a loved one) has cancer, but the latest round of chemotherapy has unfortunately had only a modest impact. While you’re acutely aware of the “wretchedness of life that becomes worn to the nub by [ chemotherapy’s] adverse effects” you’re also a fighter. How do you decide whether to continue with chemo? The answer to that question is both intimately personal and inextricably tied to health policy. Cancer is the leading cause of death among those aged 60 to 79, and it is the second leading cause of death for all Americans. With expenditures on cancer care expected to top $158 bill...
Source: The Health Care Blog - May 11, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Chemotherapy Millenson Oncology shared decision making Source Type: blogs

Negotiated Rates: What No One Talks About in Health Care Legislation
Last week, the House of Representatives passed legislation for the American Health Care Act, the first step in repealing the Affordable Care Act, or as some would call it, Trumpcare versus Obamacare.  The American Psychiatric Association and the American Medical Association (and many other medical societies) oppose the new legislation.  An enormous concern is that the new legislation won't require insurance companies to cover preexisting conditions, or require coverage for mental health treatment or prenatal/maternity care.  Over the coming years, the new legislation is predicted to leave 24 million more Ame...
Source: Shrink Rap - May 7, 2017 Category: Psychiatry Authors: Dinah Source Type: blogs

Not Really Insurance: The Pre-Existing Condition Debate
By DAVID DRANOVE and CRAIG GARTHWAITE The recent debate over the potential repeal and replacement of the ACA, with the current focus on coverage for preexisting conditions, has drawn a great deal of attention to the concept of health insurance.  While our political leaders are constantly talking about it, few of them seem to understand the “insurance” component of health insurance. As a result, much of what they say about preexisting condition coverage is gibberish. We are here to set the record straight. At its most basic level, insurance provides protection against the risk of unexpected financial losses. We focus o...
Source: The Health Care Blog - May 6, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Free Rider Insurance Pre-Existing Condition risk Source Type: blogs

Thanks to the AHCA We Could Now See Cervical Cancer Rates Increase
By ILANA ADDIS, MD In 2014 I took my first trip to Kenya. After my plane landed in Nairobi I rode for 10 hours with my medical colleagues to Bungoma, a town on the western edge of the country. We set up our clinic in the local hospital and then spent the week training local healthcare providers on a technique called ‘Visual Inspection with Acetic Acid (VIA)’. This is an inexpensive method to screen for cervical cancer and pre-cancer in low resource settings using vinegar. As a part of the training we screened 189 women for cervical cancer in that week. The Papaniculou (pap) smear was revolutionary in cervical cancer pr...
Source: The Health Care Blog - May 4, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Cervical Cancer MacArthur Amendment Source Type: blogs

We Could Now See Cervical Cancer Rates Increase
By ILANA ADDIS, MD In 2014 I took my first trip to Kenya. After my plane landed in Nairobi I rode for 10 hours with my medical colleagues to Bungoma, a town on the western edge of the country. We set up our clinic in the local hospital and then spent the week training local healthcare providers on a technique called ‘Visual Inspection with Acetic Acid (VIA)’. This is an inexpensive method to screen for cervical cancer and pre-cancer in low resource settings using vinegar. As a part of the training we screened 189 women for cervical cancer in that week. The Papaniculou (pap) smear was revolutionary in cervical cancer pr...
Source: The Health Care Blog - May 4, 2017 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Cervical Cancer MacArthur Amendment Source Type: blogs

Genentech Beats FCA Suit, Thanks to Escobar
On Monday, May 1, 2017, the United States Court of Appeals for the Third Circuit stopped a False Claims Act suit that accused Genentech Inc. of defrauding Medicare by concealing certain side effects of its cancer drug Avastin, stating that the whistleblower did not show that failing to report such safety information was relevant to government reimbursement for medication. Prior to filing his qui tam suit, The relator, Gerasimos Petratos, a prior global head of health care data analytics for Genentech, allegedly recommended implementing a different database that he believed would more accurately reflect the drug’s side e...
Source: Policy and Medicine - May 4, 2017 Category: American Health Authors: Thomas Sullivan - Policy & Medicine Writing Staff Source Type: blogs

Health Datapalooza 2017 Day 1: Data Liberation, Sharing, and Analytics
Welcome to Medgadget‘s coverage of Health Datapalooza 2017, an AcademyHealth event, in Washington, DC. The now annual event was launched in 2010 by the Obama administration as a hackathon-style program where attendees were challenged to deve...
Source: Medgadget - May 1, 2017 Category: Medical Equipment Authors: Michael Batista Tags: Exclusive Source Type: blogs